Drug Profile
Research programme: hygromycin A analogues - Pfizer
Alternative Names: CE-129941; CE-156811Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Peptidyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Bacterial-infections in USA (IV)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Bacterial-infections in USA (PO)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Bacterial-infections in USA (SC)